Johnson & Johnson
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| JNJB34.SA | JNJ.NE | LLY.NE | MRK | AZN.L | 4552.T | |
|---|---|---|---|---|---|---|
| Market cap | 3.62T | 915.54B | 1.74T | 370.96B | 218.15B | 64.55B |
| P/E (TTM) | 43.8 | 25.4 | 65.7 | 151.9 | 26.7 | — |
| Forward P/E | — | — | — | 16.7 | 16.6 | 14.4 |
| Price/book | 8.8 | 0.8 | 1.4 | 8.9 | 5.6 | 1.6 |
| Dividend yield | 1.78% | 2.49% | 0.58% | 2.26% | 1.70% | 3.97% |
| 1-year change | +51.24% | +40.84% | +35.37% | +75.29% | +9.27% | −17.24% |
| Today | +3.45% | +4.32% | +0.78% | +3.93% | +0.30% | +4.96% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All JNJB34.SA news ›Top Players Alcon, AbbVie, Bausch + Lomb, and Johnson & Johnson in the Artificial Tears Market as It Reaches USD 6.5 Billion by 2036, Growing at 5.2% CAGR
Press release - Future Market Insights - Top Players Alcon, AbbVie, Bausch + Lomb, and Johnson & Johnson in the Artificial Tears Market as It Reaches USD 6.5 Billion by 2036, Growing at 5.2% CAGR - published on openPR.com Top Players…
The Real Madrid Foundation and Johnson & Johnson promote prostate cancer awareness through their message-driven match
Real Madrid veterans and Johnson & Johnson employees participated in a new edition of the campaign ‘Don’t Get Caught Offside.’ The Real Madrid Foundation and Johnson & Johnson continue with the campaign ‘Don’t Get Caught Offside,’ an…
Johnson & Johnson $JNJ Stock Sold by Welch Group LLC
Posted by Michael Walen on Nov 3rd, 2026 The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 8th. Investors of record on Tuesday, November 24th will be issued a dividend of $1.34 per share.…
Johnson & Johnson $JNJ Stock Holdings Lessened by Trek Financial LLC
Posted by Michael Walen on Nov 3rd, 2026 Get Our Latest Report on JNJ The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 8th. Stockholders of record on Tuesday, November 24th will be issued a…
More from 1 other outlet
On the benefits of earlier oncological intervention, with Johnson & Johnson
As ESMO 2026 came to a close, Nicole Raleigh spoke with Johnson & Johnson Innovative Medicine’s Carolyn Sousa, VP, EMEA Commercial Strategy Lead – Oncology, and Henar Hevia, Senior Director, EMEA Therapeutic Area Lead, Oncology. The…
Johnson & Johnson: A Quality Healthcare Giant, Fairly Priced For Growth
Johnson & Johnson's Innovative Medicine segment outperforms, driven by Darzalex, Tremfya, and promising pipeline drugs. See why I rate JNJ stock a Hold. - Johnson & Johnson is rated Hold, with strong pharmaceutical momentum but limited…
What Will Decide Johnson & Johnson Stock Over The Next Six Months?
Johnson & Johnson’s Outlook For 2027 Johnson & Johnson will give more detail on its 2027 outlook at its enterprise business review on December 8, 2026. The sales side holds so far: management raised the midpoint of its 2026 operational…
Has The Story Under Johnson & Johnson Stock Run Out?
J&J’s 2025 Reports Showed Sales Growth Picking Up You could have seen some of it, starting in J&J’s own quarterly reports. In a report filed on April 23, 2025, sales for the quarter ended March 2025 grew 2.4% from a year earlier. That…
Law firm investigates Johnson & Johnson over Q3 earnings and revenue miss amid talc litigation costs.
Pomerantz LLP is investigating Johnson & Johnson for potential securities fraud following the company's Q3 2026 report, which showed net earnings of $210 million due to large charges from talc litigation settlements. The MedTech segment's…
Johnson & Johnson reports 94% success rate in trial of coronary artery device
Johnson & Johnson’s Shockwave Javelin showed strong 30-day trial results in complex coronary artery disease. yuelan/iStock Editorial via Getty Images Johnson & Johnson (JNJ) on Sunday reported positive 30-day results from a clinical trial…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com28
- defenseworld.net18
- gurufocus.com17
- seekingalpha.com14
- fool.com13
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.